208 related articles for article (PubMed ID: 29992762)
1. Increased survival of patients aged 0-29 years with osteosarcoma: A period analysis, 1984-2013.
Wu J; Sun H; Li J; Guo Y; Zhang K; Lang C; Zou C; Ma H
Cancer Med; 2018 Aug; 7(8):3652-3661. PubMed ID: 29992762
[TBL] [Abstract][Full Text] [Related]
2. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.
Mirabello L; Troisi RJ; Savage SA
Cancer; 2009 Apr; 115(7):1531-43. PubMed ID: 19197972
[TBL] [Abstract][Full Text] [Related]
3. Osteosarcoma: A Surveillance, Epidemiology, and End Results program-based analysis from 1975 to 2017.
Cole S; Gianferante DM; Zhu B; Mirabello L
Cancer; 2022 Jun; 128(11):2107-2118. PubMed ID: 35226758
[TBL] [Abstract][Full Text] [Related]
4. Demographic determinants of survival in osteosarcoma.
Nathan SS; Healey JH
Ann Acad Med Singap; 2012 Sep; 41(9):390-9. PubMed ID: 23052433
[TBL] [Abstract][Full Text] [Related]
5. Incidence and survival rates among pediatric osteogenic sarcoma cases in Khon Kaen, Thailand, 1985-2010.
Wiromrat P; Jetsrisuparb A; Komvilaisak P; Sirichativapee W; Kamsa-Ard S; Wiangnon S
Asian Pac J Cancer Prev; 2012; 13(9):4281-4. PubMed ID: 23167328
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology of osteosarcoma.
Ottaviani G; Jaffe N
Cancer Treat Res; 2009; 152():3-13. PubMed ID: 20213383
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Survival Rates of Patients with Stage III-IV Hodgkin Lymphoma According to Age, Sex, Race, and Socioeconomic Status, 1984-2013.
Li Y; Sun H; Yan Y; Sun T; Wang S; Ma H
Oncologist; 2018 Nov; 23(11):1328-1336. PubMed ID: 29739895
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in high-grade pediatric osteosarcoma among children and young adults: Greek Nationwide Registry for Childhood Hematological Malignancies and Solid Tumors (NARECHEM-ST) data along with a systematic review and meta-analysis.
Papakonstantinou E; Athanasiadou KI; Markozannes G; Tzotzola V; Bouka E; Baka M; Moschovi M; Polychronopoulou S; Hatzipantelis E; Galani V; Stefanaki K; Strantzia K; Vousvouki M; Kourou P; Magkou E; Nikita M; Zambakides C; Michelarakis J; Alexopoulou A; Gavra M; Malama A; Ntzani EE; Petridou ET
Cancer Epidemiol; 2024 Jun; 90():102551. PubMed ID: 38447251
[TBL] [Abstract][Full Text] [Related]
9. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
10. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
[TBL] [Abstract][Full Text] [Related]
11. Improved survival in multiple myeloma, with a diminishing racial gap and a widening socioeconomic status gap over three decades.
Sun T; Wang S; Sun H; Wen J; An G; Li J
Leuk Lymphoma; 2018 Jan; 59(1):49-58. PubMed ID: 28595471
[TBL] [Abstract][Full Text] [Related]
12. Osteosarcoma in New Zealand 1981-7: an overview.
Mills HJ; Horne G; Devane P
N Z Med J; 1995 Nov; 108(1011):458-9. PubMed ID: 8538963
[TBL] [Abstract][Full Text] [Related]
13. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE
Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228
[TBL] [Abstract][Full Text] [Related]
14. Pediatric head and neck bone sarcomas: An analysis of 204 cases.
Brady JS; Chung SY; Marchiano E; Eloy JA; Baredes S; Park RCW
Int J Pediatr Otorhinolaryngol; 2017 Sep; 100():71-76. PubMed ID: 28802390
[TBL] [Abstract][Full Text] [Related]
15. Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma.
Berner K; Johannesen TB; Berner A; Haugland HK; Bjerkehagen B; Bøhler PJ; Bruland ØS
Acta Oncol; 2015 Jan; 54(1):25-33. PubMed ID: 24957555
[TBL] [Abstract][Full Text] [Related]
16. Making a case for the socioeconomic determinacy of survival in osteosarcoma.
Nathan SS; Healey JH
Clin Orthop Relat Res; 2013 Mar; 471(3):784-91. PubMed ID: 22972655
[TBL] [Abstract][Full Text] [Related]
17. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
18. Insurance impacts survival for children, adolescents, and young adults with bone and soft tissue sarcomas.
Penumarthy NL; Goldsby RE; Shiboski SC; Wustrack R; Murphy P; Winestone LE
Cancer Med; 2020 Feb; 9(3):951-958. PubMed ID: 31838786
[TBL] [Abstract][Full Text] [Related]
19. Osteosarcoma in New Zealand: an outcome study comparing survival rates between 1981-1987 and 1994-1999.
Curry H; Horne G; Devane P; Tobin H
N Z Med J; 2006 Sep; 119(1242):U2234. PubMed ID: 16998576
[TBL] [Abstract][Full Text] [Related]
20. Osteosarcoma: improvement in survival limited to high-grade patients only.
Jawad MU; Cheung MC; Clarke J; Koniaris LG; Scully SP
J Cancer Res Clin Oncol; 2011 Apr; 137(4):597-607. PubMed ID: 20514491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
